1.77
price down icon4.84%   -0.09
after-market Handel nachbörslich: 1.80 0.03 +1.69%
loading

Tempest Therapeutics Inc Aktie (TPST) Neueste Nachrichten

pulisher
May 23, 2026

Tempest Therapeutics Inc. (TPST) Q1 2026 Earnings: Significant EPS Miss with No Revenue; Stock Edges UpInterim Report - Newser

May 23, 2026
pulisher
May 23, 2026

Tempest Therapeutics, Inc. 8-K Filing Details and Entity Information for May 19, 2026 - Minichart

May 23, 2026
pulisher
May 22, 2026

Tempest Therapeutics (TPST) Edges Higher as Biotech Sector Shows Renewed InterestDiamond Pattern - Newser

May 22, 2026
pulisher
May 22, 2026

Tempest Therapeutics announces resignation of three board members By Investing.com - Investing.com Australia

May 22, 2026
pulisher
May 22, 2026

Tempest Therapeutics announces resignation of three board members - Investing.com

May 22, 2026
pulisher
May 22, 2026

Tempest Therapeutics Faces Nasdaq Listing and Governance Risks - TipRanks

May 22, 2026
pulisher
May 22, 2026

Tempest Therapeutics Announces Multiple Board Director Resignations - TipRanks

May 22, 2026
pulisher
May 22, 2026

Tempest Therapeutics receives Nasdaq notice for listing deficiencies - Investing.com UK

May 22, 2026
pulisher
May 22, 2026

Tempest Therapeutics receives Nasdaq notice for listing deficiencies By Investing.com - Investing.com Canada

May 22, 2026
pulisher
May 22, 2026

Nasdaq flags Tempest Therapeutics (NASDAQ: TPST) on equity and board gaps - Stock Titan

May 22, 2026
pulisher
May 22, 2026

[8-K] Tempest Therapeutics, Inc. Reports Material Event - Stock Titan

May 22, 2026
pulisher
May 20, 2026

Tempest Therapeutics (TPST) Stock: Jumps +3.65%, Approaching $1.93 2026-05-20Percent Below MA - Newser

May 20, 2026
pulisher
May 15, 2026

Press Releases about Tempest Therapeutics, Inc.Common Stock - The Chronicle-Journal

May 15, 2026
pulisher
May 14, 2026

Tempest Therapeutics | 10-Q: Q1 2026 Earnings Report - Moomoo

May 14, 2026
pulisher
May 14, 2026

Tempest Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

May 14, 2026
pulisher
May 14, 2026

Tempest Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 14, 2026
pulisher
May 14, 2026

Tempest Therapeutics (NASDAQ: TPST) Q1 2026 loss widens on CAR-T deal charges and low cash - Stock Titan

May 14, 2026
pulisher
May 14, 2026

Tempest Therapeutics reports Q1 2026 net loss of $27.7M, cash $1.8M - TradingView

May 14, 2026
pulisher
May 14, 2026

Tempest Therapeutics Q1 net loss widens on asset acquisition costs - TradingView

May 14, 2026
pulisher
May 14, 2026

Tempest Therapeutics (TPST) posts $27.7M loss, highlights 100% CAR‑T responses - Stock Titan

May 14, 2026
pulisher
May 14, 2026

Tempest CAR-T trials log 100% response in 15 patients - Stock Titan

May 14, 2026
pulisher
May 14, 2026

Tempest Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewswire

May 14, 2026
pulisher
May 14, 2026

MSN Money - MSN

May 14, 2026
pulisher
May 12, 2026

TradingKey - TradingKey

May 12, 2026
pulisher
May 08, 2026

Tempest Therapeutics Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView

May 08, 2026
pulisher
May 06, 2026

Tempest Therapeutics Showcases Strong TPST-2003 CAR-T Data - TipRanks

May 06, 2026
pulisher
May 06, 2026

Tempest presents TPST-2003 interim data: 100% CR in 15 CAR-T‑naïve patients, median PFS 23.1 months - TradingView

May 06, 2026
pulisher
May 06, 2026

Tempest Therapeutics | 8-K: Current report - Moomoo

May 06, 2026
pulisher
May 06, 2026

TPST-2003 delivers 100% CRs in rrMM, Tempest (NASDAQ: TPST) says - Stock Titan

May 06, 2026
pulisher
May 06, 2026

Tempest Presents Clinical Update at ISCT 2026 Annual Meeting - GlobeNewswire

May 06, 2026
pulisher
May 01, 2026

TPST Tempest Therapeutics tops Q4 2025 EPS estimates, shares jump more than 14 percent in today’s trading.Trending Buy Opportunities - Newser

May 01, 2026
pulisher
Apr 30, 2026

TPST Q1'26 Earnings: revenue estimate is 0 USD - TradingView

Apr 30, 2026
pulisher
Apr 29, 2026

After six complete responses, Tempest brings updated CAR-T data to Dublin - Stock Titan

Apr 29, 2026
pulisher
Apr 29, 2026

Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting - GlobeNewswire

Apr 29, 2026
pulisher
Apr 25, 2026

TPST Stock Plummets After Inking Deal To Acquire CAR-T Programs From Privately-Held Firm In All-Stock Transaction - MSN

Apr 25, 2026
$29.66
price down icon 0.98%
$92.25
price up icon 0.12%
$108.87
price up icon 2.48%
$53.86
price down icon 1.17%
ONC ONC
$302.44
price down icon 2.52%
$154.89
price up icon 2.20%
Kapitalisierung:     |  Volumen (24h):